420 related articles for article (PubMed ID: 27450657)
61. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
62. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
[TBL] [Abstract][Full Text] [Related]
63. The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma.
Liu N; Guo W; Shi Q; Zhuang W; Pu X; Chen S; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Gan W; Li D
Sci Rep; 2020 Oct; 10(1):16361. PubMed ID: 33004995
[TBL] [Abstract][Full Text] [Related]
64. Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.
Funasaki S; Mehanna S; Ma W; Nishizawa H; Kamikubo Y; Sugiyama H; Ikeda S; Motoshima T; Hasumi H; Linehan WM; Schmidt LS; Ricketts C; Suda T; Oike Y; Kamba T; Baba M
Cancer Sci; 2022 Jul; 113(7):2352-2367. PubMed ID: 35396773
[TBL] [Abstract][Full Text] [Related]
65. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
66. Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement.
Fall B; Sarr A; Sow Y; Diao B
Afr J Paediatr Surg; 2011; 8(3):317-9. PubMed ID: 22248899
[TBL] [Abstract][Full Text] [Related]
67. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
[TBL] [Abstract][Full Text] [Related]
68. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.
Kato H; Kanematsu M; Yokoi S; Miwa K; Horie K; Deguchi T; Hirose Y
J Magn Reson Imaging; 2011 Jan; 33(1):217-20. PubMed ID: 21182142
[TBL] [Abstract][Full Text] [Related]
69. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
[TBL] [Abstract][Full Text] [Related]
70. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.
Liu N; Chen Y; Yang L; Shi Q; Lu Y; Ma W; Han X; Guo H; Li D; Gan W
Clin Transl Med; 2022 Apr; 12(4):e797. PubMed ID: 35452181
[TBL] [Abstract][Full Text] [Related]
71. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.
Suzigan S; Drut R; Faria P; Argani P; De Marzo AM; Barbosa RN; Mello Denadai ER; Martins-Filho J; Martucci RC; Bauab T
Int J Surg Pathol; 2007 Apr; 15(2):199-203. PubMed ID: 17478783
[TBL] [Abstract][Full Text] [Related]
72. MiT family translocation renal cell carcinoma in an elderly male.
Prachi ; Aiyer HM
Indian J Pathol Microbiol; 2021; 64(3):553-555. PubMed ID: 34341271
[TBL] [Abstract][Full Text] [Related]
73. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.
Sukov WR; Hodge JC; Lohse CM; Leibovich BC; Thompson RH; Pearce KE; Wiktor AE; Cheville JC
Am J Surg Pathol; 2012 May; 36(5):663-70. PubMed ID: 22498819
[TBL] [Abstract][Full Text] [Related]
74. Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).
Hirobe M; Masumori N; Tanaka T; Kitamura H; Tsukamoto T
Cancer Biol Ther; 2013 Jun; 14(6):502-10. PubMed ID: 23760492
[TBL] [Abstract][Full Text] [Related]
75. Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.
Cheng X; Gan W; Zhang G; Li X; Guo H
BMC Urol; 2016 Jul; 16(1):40. PubMed ID: 27401463
[TBL] [Abstract][Full Text] [Related]
76. Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.
Saleeb RM; Srigley JR; Sweet J; Doucet C; Royal V; Chen YB; Brimo F; Evans A
Pathol Res Pract; 2017 Nov; 213(11):1412-1418. PubMed ID: 28969862
[TBL] [Abstract][Full Text] [Related]
77. A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion.
Ye H; Qin S; Li N; Lin M; Xu Y; Li X
Biomed Res Int; 2019; 2019():5974089. PubMed ID: 31828108
[TBL] [Abstract][Full Text] [Related]
78. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
Chang IW; Huang HY; Sung MT
Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274
[TBL] [Abstract][Full Text] [Related]
79. Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions.
Liu C; Zhang W; Song H
J Pediatr Surg; 2017 Sep; 52(9):1492-1495. PubMed ID: 28365106
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y; Zhao C; Wang Z; Liu F; Zhao M; Yang H; Chen J; Chen X; Shi M; Jiang D; Luo X; Duan Y; Bai Y
Aging (Albany NY); 2024 Jan; 16(2):1696-1711. PubMed ID: 38261736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
